Stephen Hahn speaks at an FDA and AACR workshop, February 2018 [via the American Association for Cancer Research]

As clock ticks, Trump will nom­i­nate Stephen Hahn as FDA com­mis­sion­er next week — re­port

Stephen Hahn is set to be nom­i­nat­ed as the next FDA com­mis­sion­er next week, the Wall Street Jour­nal has re­port­ed.

With the clock tick­ing to­ward the No­vem­ber 1 dead­line, Pres­i­dent Don­ald Trump is cut­ting it close. But Hahn, the chief med­ical ex­ec­u­tive at Hous­ton’s MD An­der­son Can­cer Cen­ter, has emerged as the fron­trun­ner to fill Scott Got­tlieb’s seat — which Ned Sharp­less has been serv­ing in an in­ter­im ca­pac­i­ty — as ear­ly as Sep­tem­ber. From pre­vi­ous re­ports, it ap­peared that Hahn was just one FBI back­ground check away from the nom­i­na­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.